Eli Lilly and Co (NYSE:LLY)’s share price was down 0.9% during mid-day trading on Friday . The stock traded as low as $76.49 and last traded at $76.54, with a volume of 1,906,320 shares trading hands. The stock had previously closed at $77.23.

Several equities analysts recently issued reports on LLY shares. Jefferies Group reiterated a “buy” rating and issued a $100.00 price objective on shares of Eli Lilly and in a research report on Friday, May 13th. Credit Suisse Group AG reiterated a “buy” rating on shares of Eli Lilly and in a research report on Thursday, May 26th. TheStreet upgraded Eli Lilly and from a “hold” rating to a “buy” rating in a research report on Friday, May 27th. Morgan Stanley reiterated a “hold” rating and issued a $88.00 price objective on shares of Eli Lilly and in a research report on Saturday, June 4th. Finally, SunTrust Banks Inc. reiterated a “buy” rating on shares of Eli Lilly and in a research report on Wednesday, June 15th. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Eli Lilly and has a consensus rating of “Buy” and an average target price of $96.58.

The stock has a market cap of $81.28 billion and a PE ratio of 33.12. The firm has a 50-day moving average of $80.39 and a 200-day moving average of $76.26.

Eli Lilly and (NYSE:LLY) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $0.86 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.86. During the same period last year, the business posted $0.90 EPS. The firm earned $5.40 billion during the quarter, compared to analyst estimates of $5.14 billion. The company’s revenue was up 8.6% on a year-over-year basis. On average, equities analysts forecast that Eli Lilly and Co will post $3.59 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 9th. Shareholders of record on Monday, August 15th will be paid a $0.51 dividend. The ex-dividend date of this dividend is Thursday, August 11th. This represents a $2.04 dividend on an annualized basis and a yield of 2.65%.

In other Eli Lilly and news, insider Donald A. Zakrowski sold 1,213 shares of the firm’s stock in a transaction that occurred on Thursday, July 28th. The stock was sold at an average price of $83.16, for a total value of $100,873.08. Following the completion of the sale, the insider now owns 1,300 shares of the company’s stock, valued at $108,108. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Melissa S. Barnes sold 992 shares of the firm’s stock in a transaction that occurred on Friday, June 10th. The shares were sold at an average price of $73.77, for a total value of $73,179.84. Following the completion of the sale, the senior vice president now directly owns 10,710 shares of the company’s stock, valued at approximately $790,076.70. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Eli Lilly and stock. American International Group Inc. increased its stake in shares of Eli Lilly and Co (NYSE:LLY) by 3.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 350,071 shares of the company’s stock after buying an additional 10,995 shares during the period. American International Group Inc.’s holdings in Eli Lilly and were worth $29,497,000 as of its most recent SEC filing.

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.